Exploring the role of inflammation in major depressive disorder: beyond the monoamine hypothesis

Exploring the role of inflammation in major depressive disorder: beyond the monoamine hypothesis

Major depressive disorder affects approximately 8.4% of the United States population. The World Health Organization estimates that 280 million adults worldwide are suffering from depression. They have estimated that by 2030 it will be the second most serious condition. Current treatment relies on th...

Full description

Bibliographic Details
Main Authors:	Irene Pastis, Melody G. Santos, Akshita Paruchuri
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Behavioral Neuroscience
Subjects:	major depressive disorder inflammation monoamine hypothesis immune pathways cytokines kynurenine
Online Access:	https://www.frontiersin.org/articles/10.3389/fnbeh.2023.1282242/full

Similar Items

Plausible Role of Stem Cell Types for Treating and Understanding the Pathophysiology of Depression
by: Punya Sachdeva, et al.
Published: (2023-03-01)

Alterations of monoamine neurotransmitters, HPA-axis hormones, and inflammation cytokines in reserpine-induced hyperalgesia and depression comorbidity rat model
by: Jingjie Zhao, et al.
Published: (2022-06-01)

Linking major depressive disorder pathogenesis with kynurenine pathway - a literature review
by: Dominik Szawica, et al.
Published: (2023-03-01)

Neuroinflammatory Hypothesis in Major Depressive Disorder
by: Gulfizar Sozeri-Varma
Published: (2014-02-01)

Monoamine Neurotransmitters Control Basic Emotions and Affect Major Depressive Disorders
by: Yao Jiang, et al.
Published: (2022-09-01)

Peripheral tryptophan and serotonin and kynurenine pathways in major depression: A case-control study
by: R. Colle, et al.
Published: (2021-04-01)

Research progress of non-monoamine antidepressants
by: Huan Zhang, et al.
Published: (2021-12-01)

The monoamine theory of depression as a target to effective pharmacotherapy
by: Karabin Tomasz, et al.
Published: (2023-06-01)

The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder
by: Hongye Liu, et al.
Published: (2018-11-01)

Association Between Major Depressive Disorder and Sleep Disturbances Through Inflammation in Adolescents
by: Abhishek Reddy, et al.
Published: (2020-09-01)

Cinnamon oil solid self-microemulsion mediates chronic mild stress-induced depression in mice by modulating monoamine neurotransmitters, corticosterone, inflammation cytokines, and intestinal flora
by: Tianyu Ma, et al.
Published: (2023-06-01)

Anti-inflammatory effects of ketamine in the treatment-resistant depression: a narrative review
by: Marta Elżbieta Jóźwiak-Bębenista, et al.
Published: (2024-02-01)

Involvement of kynurenine pathway between inflammation and glutamate in the underlying etiopathology of CUMS-induced depression mouse model
by: Xingying Wu, et al.
Published: (2022-11-01)

Tryptophan catabolites and depression in the general population: results from the Gutenberg Health Study
by: Matthias Michal, et al.
Published: (2023-01-01)

Early Life Stress Induced DNA Methylation of Monoamine Oxidases Leads to Depressive-Like Behavior
by: Qiuyue Xu, et al.
Published: (2020-09-01)

Implications of Systemic Inflammation and Periodontitis for Major Depression
by: Sadayuki Hashioka, et al.
Published: (2018-07-01)

Changes in tryptophan breakdown associated with response to multimodal treatment in depression
by: Eva Z. Reininghaus, et al.
Published: (2024-06-01)

Tibetan mineral-herbal medicine Zuotai alleviates the depressive-like behaviors in chronic restraint-stressed mice while regulating stress hormone, inflammation and monoamine
by: Cen Li, et al.
Published: (2023-11-01)

Simulated synapse loss induces depression-like behaviors in deep reinforcement learning
by: Eric Chalmers, et al.
Published: (2024-11-01)

Systemic Tumors Can Cause Molecular Changes in the Hippocampus That May Have an Impact on Behavior after Chronic Social Stress
by: Olatz Goñi-Balentziaga, et al.
Published: (2024-06-01)

Markers of Inflammation and Monoamine Metabolism Indicate Accelerated Aging in Bipolar Disorder
by: Seline van den Ameele, et al.
Published: (2018-06-01)

Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression
by: Haixia Wang, et al.
Published: (2022-06-01)

Comparison of serum kynurenine pathway metabolites between patients with first-episode and recurrent major depressive disorder
by: Lao Guohui, et al.
Published: (2023-08-01)

Kynurenines and Inflammation: A Remarkable Axis for Multiple Sclerosis Treatment
by: Paul Carrillo-Mora, et al.
Published: (2024-07-01)

Is the chemical imbalance an ‘urban legend’? An exploration of the status of the serotonin theory of depression in the scientific literature
by: Benjamin Ang, et al.
Published: (2022-12-01)

The Kynurenine Pathway in Healthy Subjects and Subjects with Obesity, Depression and Chronic Obstructive Pulmonary Disease
by: Per G. Farup, et al.
Published: (2023-02-01)

TAARs as Novel Therapeutic Targets for the Treatment of Depression: A Narrative Review of the Interconnection with Monoamines and Adult Neurogenesis
by: Taisiia S. Shemiakova, et al.
Published: (2024-06-01)

The kynurenine pathway of tryptophan catabolism and schizophrenia
by: Marković Miloš, et al.
Published: (2023-01-01)

Inflammation and severity of depressive symptoms in physically active individuals after COVID-19 – An exploratory immunopsychological study investigating the effect of inflammation on depressive symptom severity
by: Lynn Matits, et al.
Published: (2023-07-01)

Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms
by: Stefano Comai, et al.
Published: (2024-01-01)

Electroacupuncture attenuates LPS-induced depression-like behavior through kynurenine pathway
by: Xingying Wu, et al.
Published: (2023-01-01)

Monoamine oxidases: A missing link between mitochondria and inflammation in chronic diseases ?
by: Lise Beucher, et al.
Published: (2024-11-01)

Relationship between serum inflammatory cytokines and suicide risk in patients with major depressive disorder
by: Yiyue Yang, et al.
Published: (2024-06-01)

The Role of Kynurenine and Its Metabolites in Comorbid Chronic Pain and Depression
by: Onella Athnaiel, et al.
Published: (2022-10-01)

Involvement of inflammatory responses in the brain to the onset of major depressive disorder due to stress exposure
by: Shingo Miyata, et al.
Published: (2022-07-01)

The inhibition of monoamine oxidase by harmine derivatives
by: Theo Myburg, et al.
Published: (2022-01-01)

Sex differences in childhood maltreatment, inflammation, and adulthood depression: A network analysis
by: Jay D. O'Shields, et al.
Published: (2023-05-01)

Dynamic quantitative monitoring of cerebrospinal fluid monoamine neurotransmitter markers during the modeling process of chronic stress‐induced depression in monkeys (Macaca mulatta)
by: Siyu Li, et al.
Published: (2024-08-01)

Serum neuroactive metabolites of the tryptophan pathway in patients with acute phase of affective disorders
by: Yanli Li, et al.
Published: (2024-04-01)

Tryptophan degradation as a systems phenomenon in inflammation – an analysis across 13 chronic inflammatory diseasesResearch in context
by: Danielle M.M. Harris, et al.
Published: (2024-04-01)